Different chemotherapy regimens may contribute differently to the development of Premature Ovarian Failure (POF) in women of reproductive age with breast cancer. Here we evaluated how two different chemotherapy regimens, CAF (tegafur + pirarubicin + ifosfamide) and DTC (docetaxel + pirarubicin + ifosfamide), affect the development of POF.

DTC chemotherapy regimen is associated with higher incidence of premature ovarian failure in women of reproductive age with breast cancer

guido m
2016-01-01

Abstract

Different chemotherapy regimens may contribute differently to the development of Premature Ovarian Failure (POF) in women of reproductive age with breast cancer. Here we evaluated how two different chemotherapy regimens, CAF (tegafur + pirarubicin + ifosfamide) and DTC (docetaxel + pirarubicin + ifosfamide), affect the development of POF.
2016
Adult
Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms
Cyclophosphamide
Docetaxel
Doxorubicin
Estradiol
Female
Fluorouracil
Follicle Stimulating Hormone
Humans
Ifosfamide
Incidence
Luteinizing Hormone
Middle Aged
Primary Ovarian Insufficiency
Reproduction
Taxoids
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11770/376999
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 15
social impact